Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1-methyl-3-phenyl-1h-pyrazol-5-ylsulfamic acid
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- (unknown)
01
Overview
This compound is a small molecule belonging to the class of organic compounds known as phenylpyrazoles. It features a pyrazole ring substituted with a methyl group at position 1 and a phenyl group at position 3, with a sulfamic acid moiety attached at position 5. The mechanism of action and primary indication are not specified in available sources. No developer or manufacturer information is available[2][8][4].
- Other names
- (2-methyl-5-phenylpyrazol-3-yl)sulfamic acidN-(1-methyl-3-phenyl-1H-pyrazol-5-yl)sulfamic acid
Beyond the preview
Go deeper on 1-methyl-3-phenyl-1h-pyrazol-5-ylsulfamic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1-methyl-3-phenyl-1h-pyrazol-5-ylsulfamic acid.